Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in

See also
Status	Clinical Trial	Phase
Completed	`NCT02705976` - Prospective Trial of a Validated Algorithm for Warfarin Dosing	N/A
Active, not recruiting	`NCT04139525` - Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane	N/A
Completed	`NCT01907048` - Patient and Physician Knowledge of Key Safety Messages
Recruiting	`NCT03419923` - Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage	N/A
Completed	`NCT03575936` - Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic	N/A
Completed	`NCT02714855` - Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France	N/A
Recruiting	`NCT01314235` - Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and Clopidogrel	N/A
Withdrawn	`NCT04059965` - AntiCoagulation Tracking InterVention and Evaluation	N/A
Recruiting	`NCT02987192` - Minimally Invasive Lumbar Aneasthesia Used for Cesarean Section	N/A
Completed	`NCT01477528` - Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
Recruiting	`NCT04405232` - Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK
Recruiting	`NCT02761941` - Excessive Warfarin Anticoagulation - Causes and Consequences	N/A
Completed	`NCT02392104` - Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service	N/A
Recruiting	`NCT03473132` - Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)	Phase 4
Enrolling by invitation	`NCT05305612` - Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions	Phase 4
Completed	`NCT03662594` - Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus Formation	N/A
Active, not recruiting	`NCT03910933` - Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative
Completed	`NCT02492828` - Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden	N/A
Completed	`NCT03684395` - Accessibility to New Drugs Versus SOC in Sweden
Completed	`NCT01124058` - Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial	Phase 1

NCT number	NCT01884337
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 4
Start date	March 24, 2015
Completion date	June 4, 2018

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms